Tariq Ahmad

30.9k total citations · 1 hit paper
131 papers, 5.2k citations indexed

About

Tariq Ahmad is a scholar working on Genetics, Immunology and Epidemiology. According to data from OpenAlex, Tariq Ahmad has authored 131 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Genetics, 47 papers in Immunology and 42 papers in Epidemiology. Recurrent topics in Tariq Ahmad's work include Inflammatory Bowel Disease (67 papers), Microscopic Colitis (32 papers) and Immunodeficiency and Autoimmune Disorders (16 papers). Tariq Ahmad is often cited by papers focused on Inflammatory Bowel Disease (67 papers), Microscopic Colitis (32 papers) and Immunodeficiency and Autoimmune Disorders (16 papers). Tariq Ahmad collaborates with scholars based in United Kingdom, United States and Pakistan. Tariq Ahmad's co-authors include Derek P. Jewell, Timothy R. Orchard, Jack Satsangi, Alessandro Armuzzi, Ian Arnott, Dermot McGovern, Stuart Bloom, Charlie W. Lees, Alastair Windsor and Sally G. Mitton and has published in prestigious journals such as The Lancet, Nature Genetics and Gastroenterology.

In The Last Decade

Tariq Ahmad

117 papers receiving 5.1k citations

Hit Papers

Guidelines for the management of inflammatory bowel disea... 2011 2026 2016 2021 2011 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tariq Ahmad United Kingdom 34 2.9k 1.9k 1.6k 1.4k 687 131 5.2k
Thomas Ochsenkühn Germany 37 2.8k 1.0× 1.9k 1.0× 1.5k 0.9× 1.6k 1.1× 520 0.8× 99 5.0k
Tim Raine United Kingdom 29 2.8k 1.0× 2.0k 1.0× 1.4k 0.8× 1.0k 0.7× 776 1.1× 97 4.9k
Daan W. Hommes Netherlands 39 3.8k 1.3× 2.5k 1.3× 1.5k 0.9× 1.9k 1.3× 1.1k 1.6× 97 7.1k
Livia Biancone Italy 42 4.0k 1.4× 2.8k 1.5× 1.9k 1.1× 1.9k 1.3× 1.1k 1.6× 199 6.9k
María Chaparro Spain 38 3.5k 1.2× 2.7k 1.4× 1.2k 0.7× 1.5k 1.0× 667 1.0× 251 5.4k
Pieter Stokkers Netherlands 45 4.0k 1.3× 2.5k 1.3× 1.4k 0.9× 2.2k 1.5× 768 1.1× 133 6.4k
David Laharie France 42 3.8k 1.3× 3.4k 1.8× 1.0k 0.6× 1.7k 1.2× 544 0.8× 207 5.8k
Xavier Roblin France 41 3.9k 1.3× 3.2k 1.6× 1.8k 1.1× 1.2k 0.9× 351 0.5× 258 5.7k
Atsushi Sakuraba United States 33 2.0k 0.7× 1.6k 0.8× 1.2k 0.7× 892 0.6× 573 0.8× 153 4.2k
Jørn Brynskov Denmark 38 3.9k 1.3× 2.7k 1.4× 1.9k 1.2× 1.3k 0.9× 665 1.0× 123 5.6k

Countries citing papers authored by Tariq Ahmad

Since Specialization
Citations

This map shows the geographic impact of Tariq Ahmad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tariq Ahmad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tariq Ahmad more than expected).

Fields of papers citing papers by Tariq Ahmad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tariq Ahmad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tariq Ahmad. The network helps show where Tariq Ahmad may publish in the future.

Co-authorship network of co-authors of Tariq Ahmad

This figure shows the co-authorship network connecting the top 25 collaborators of Tariq Ahmad. A scholar is included among the top collaborators of Tariq Ahmad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tariq Ahmad. Tariq Ahmad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Plevris, Nikolas, Beatriz Gros, James Goodhand, et al.. (2024). P823 Real-world effectiveness of upadacitinib in Crohn's disease; a UK multicentre retrospective cohort study. Journal of Crohn s and Colitis. 18(Supplement_1). i1523–i1525.
4.
McGovern, Dermot, Michael A. Kamm, Dalin Li, et al.. (2023). Tu1767 BASELINE CLEARANCE FOR ANTI TUMOR NECROSIS FACTORS PREDICTS LACK OF DISEASE CONTROL DURING MAINTENANCE TREATMENT OF CROHN'S DISEASE WITH INFLIXIMAB AND ADALIMUMAB. Gastroenterology. 164(6). S–1117. 1 indexed citations
5.
Lin, Simeng, Eilís Hannon, Jeffrey F. Waring, et al.. (2023). DOP88 Understanding the molecular mechanisms of anti-TNF treatment failure: Whole blood DNA methylation changes associated with primary non-response to anti-TNF treatment in patients with Crohn’s disease. Journal of Crohn s and Colitis. 17(Supplement_1). i164–i166. 2 indexed citations
6.
Lin, Simeng, Eilís Hannon, Mark Reppell, et al.. (2023). Whole Blood DNA Methylation Changes Are Associated with Anti-TNF Drug Concentration in Patients with Crohn’s Disease. Journal of Crohn s and Colitis. 18(8). 1190–1201. 7 indexed citations
7.
Chanchlani, Neil, Simeng Lin, Rachel Nice, et al.. (2023). Pretreatment Vitamin D Concentrations Do Not Predict Therapeutic Outcome to Anti-TNF Therapies in Biologic-Naïve Patients With Active Luminal Crohn’s Disease. Crohn s & Colitis 360. 5(3). otad026–otad026. 5 indexed citations
11.
Chanchlani, Neil, Simeng Lin, Benjamin Hamilton, et al.. (2021). HMO-4 Immunogenicity to second anti-TNF therapy (IMSAT): implications for sequencing of biologic therapy. A31.2–A32.
12.
Walker, G, Neil Chanchlani, Amanda Thomas, et al.. (2020). Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy study. Archives of Disease in Childhood. 105(10). 957–963. 5 indexed citations
13.
Walker, G, Simeng Lin, Neil Chanchlani, et al.. (2020). Quality improvement project identifies factors associated with delay in IBD diagnosis. Alimentary Pharmacology & Therapeutics. 52(3). 471–480. 20 indexed citations
14.
Nice, Rachel, Neil Chanchlani, Harry Green, et al.. (2020). Validating the positivity thresholds of drug‐tolerant anti‐infliximab and anti‐adalimumab antibody assays. Alimentary Pharmacology & Therapeutics. 53(1). 128–137. 10 indexed citations
15.
Chee, Desmond, Benjamin Hamilton, Neel Heerasing, et al.. (2020). Root‐cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 53(2). 291–301. 16 indexed citations
16.
Hamilton, Benjamin, Harry Green, Neel Heerasing, et al.. (2020). Incidence and prevalence of inflammatory bowel disease in Devon, UK. Frontline Gastroenterology. 12(6). 461–470. 18 indexed citations
17.
Biasci, Daniele, James Lee, Nurulamin M Noor, et al.. (2019). A blood-based prognostic biomarker in IBD. Gut. 68(8). 1386–1395. 127 indexed citations
18.
Green, Harry, Robin N. Beaumont, Amanda Thomas, et al.. (2019). Genome-Wide Association Study of Microscopic Colitis in the UK Biobank Confirms Immune-Related Pathogenesis. Journal of Crohn s and Colitis. 13(12). 1578–1582. 31 indexed citations
19.
Lee, James, et al.. (2009). Pneumocystis jiroveci pneumonia and pneumomediastinum in an anti-TNFα naive patient with ulcerative colitis. World Journal of Gastroenterology. 15(15). 1897–1897. 16 indexed citations
20.
Yang, Xiaohong, Alessandro Armuzzi, Tariq Ahmad, et al.. (2002). The intercellular adhesion molecule-1 polymorphisms in IBD. Gut. 50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026